Return to homepagePandemic Pact

Prophylaxis of at risks persons with an ultrapotent SARS-CoV-2-neutralizing antibody

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $340,591.66

  • Funder

    FWO Belgium

  • Principal Investigator

    Xavier Saelens, Johan Neyts, Nico Callewaert, Dirk Jochmans
    …

  • Research Location

    Belgium

  • Lead Research Institution

    Katholieke Universiteit Leuven, Ghent University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract